Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated

PHASE4CompletedINTERVENTIONAL
Enrollment

1,260

Participants

Timeline

Start Date

November 27, 2022

Primary Completion Date

January 24, 2023

Study Completion Date

January 24, 2023

Conditions
Seasonal Influenza
Interventions
BIOLOGICAL

Quadrivalent Influenza Vaccine (Split Virion), inactivated

The Quadrivalent Influenza Vaccine manufactured by Sinovac Biotech Co.,Ltd. The four influenza strains(including 4 antigens H1N1, H3N2, BV and BY, 15μg for each) in 0.5 mL of sodium chloride,disodium hydrogen phosphate,sodium dihydrogen phosphate water for per injection.The routine of administration is intramuscular injection into deltoid region.And the immunization schedule is one dose of quadrivalent influenza vaccine on day 0.

Trial Locations (1)

554099

Yuping Dong Autonomous County Center for Disease Control and Prevention, Zhumadian

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY